ERBB2-amplified lobular breast carcinoma exhibits concomitant CDK12 co-amplification associated with poor prognostic features.
Journal Information
Full Title: J Pathol Clin Res
Abbreviation: J Pathol Clin Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Evidence found in paper:
"raw data for the graphics are described in detail in table 3"
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest statement: JR reports employment in Foundation Medicine and equity positions in Roche Holdings, Celsius Therapeutics and Tango Therapeutics (consultant to both companies). ZV reports advisory activity for Daiichi, Roche Diagnostic, MSD, and Exact Sciences. All other authors declare no conflicts of interest."
Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025